Is Pramlintide FDA approved?

Pramlintide is FDA approved (FDA status current as of 2005-03-16). This regulatory status is provided for research and educational context only.

How is 5-Amino-1MQ administered in research settings?

In research settings, 5-Amino-1MQ is typically administered via the oral route. PeptideBase does not provide dosing or administration instructions.

How is Pramlintide administered in research settings?

In research settings, Pramlintide is typically administered via the subcutaneous route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›5-Amino-1MQ vs Pramlintide

Peptide Comparison

5-Amino-1MQ vs Pramlintide

Name: 5-Amino-1MQ vs Pramlintide — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Metabolic peptides.

5-Amino-1MQ

5-Amino-1-methylquinolinium

Fat LossResearch Only

49 providers listed

Full 5-Amino-1MQ profile →

Pramlintide

Symlin

Fat LossFDA ApprovedPrescription

Half-life: ~48 minutes

No providers listed yet

Full Pramlintide profile →

Bottom line

Pramlintide is FDA-approved, while 5-Amino-1MQ is unknown — the clearest structural difference between them.

Quick Verdict

5-Amino-1MQ

Evidence

Preclinical

Half-life

—

Pramlintide

Evidence

Clinical

Half-life

~48 minutes

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Pramlintide
Further along in FDA review	Pramlintide
Oral administration option	5-Amino-1MQ
More provider options (49 vs 0)	5-Amino-1MQ

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

5-Amino-1MQ

Pramlintide

Mechanism Family

Metabolic

Half-life

—

~48 minutes

FDA Status

unknown

approved

Admin Routes

oral

subcutaneous

Availability

Research Only

Prescription

Providers

49 listed

None listed

FDA Update

—

Mar 2005

Avail. Notes

—

FDA-approved amylin analog. Brand: Symlin (NDA 021332, Mar 2005). Adjunct to insulin therapy in T1D and T2D. Prescription only. Subcutaneous injection.

Research Evidence

5-Amino-1MQ

PreclinicalAnimal · 1 key study · most recent 2022

Pramlintide

ClinicalRCT · 4 key studies · most recent 2026

Research Citations

5-Amino-1MQ

Animal2022 · Scientific Reports

NNMT inhibitor in diet-induced obese mice: effects on body weight, body fat, and energy expenditure

Pramlintide

RCT2007 · American Journal of Physiology: Endocrinology and Metabolism

Pramlintide reduced 24-h caloric intake and increased satiety in obese subjects: a randomized, double-blind,…

Cohort2026 · J Pharm Biomed Anal

In vitro metabolic profiling of weight-loss-inducing amylin receptor agonists in the context of preventive do…

RCT2009 · Obesity

Pramlintide combined with metreleptin in obesity: sustained reductions in weight, metabolic markers, and lept…

Review2006

Pramlintide.

About 5-Amino-1MQ

Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms.

Research Areas

fat cell reductionmetabolic rateadipose tissue modulation

About Pramlintide

Synthetic amylin analogue; activates amylin receptors in hypothalamus; slows gastric emptying, suppresses glucagon, enhances satiety

Research Areas

appetite suppressionpostprandial glucose controlweight lossgastric emptying delay

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

5-Amino-1MQ

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Pramlintide

Reported (Unverified — Pending Clinical Review)

hypoglycemia unawarenessgastroparesis

No established clinical contraindications

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Price (per mg)

5-Amino-1MQ

$5.00/mg

$2.88 – $8.00 range

20 vendors

View price index →Find providers →

Pramlintide

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

Providers offering

5-Amino-1MQ

49 listed

Browse directory →

Providers offering

Pramlintide

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Metabolic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 27, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). 5-Amino-1MQ vs Pramlintide — Per-mg Price Comparison. Retrieved July 29, 2026, from https://peptidebase.io/peptides/compare/5-amino-1mq/pramlintide

https://peptidebase.io/peptides/compare/5-amino-1mq/pramlintide Methodology License Download JSON Download CSV